Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema: the choice of second-line corticosteroid should be left to the clinical judgement of the treating physician” - Jonas, Jost B. (Ophthalmologica, 2018)
Gesehen am 15.04.2020
Published online: December 21, 2017